Innate immunity restricts Citrobacter rodentium A/E pathogenesis initiation to an early window of opportunity

PLoS Pathog. 2017 Jun 29;13(6):e1006476. doi: 10.1371/journal.ppat.1006476. eCollection 2017 Jun.

Abstract

Citrobacter rodentium infection is a mouse model for the important human diarrheal infection caused by enteropathogenic E. coli (EPEC). The pathogenesis of both species is very similar and depends on their unique ability to form intimately epithelium-adherent microcolonies, also known as "attachment/effacement" (A/E) lesions. These microcolonies must be dynamic and able to self-renew by continuous re-infection of the rapidly regenerating epithelium. It is unknown whether sustained epithelial A/E lesion pathogenesis is achieved through re-infection by planktonic bacteria from the luminal compartment or local spread of sessile bacteria without a planktonic phase. Focusing on the earliest events as C. rodentium becomes established, we show here that all colonic epithelial A/E microcolonies are clonal bacterial populations, and thus depend on local clonal growth to persist. In wild-type mice, microcolonies are established exclusively within the first 18 hours of infection. These early events shape the ongoing intestinal geography and severity of infection despite the continuous presence of phenotypically virulent luminal bacteria. Mechanistically, induced resistance to A/E lesion de-novo formation is mediated by TLR-MyD88/Trif-dependent signaling and is induced specifically by virulent C. rodentium in a virulence gene-dependent manner. Our data demonstrate that the establishment phase of C. rodentium pathogenesis in vivo is restricted to a very short window of opportunity that determines both disease geography and severity.

MeSH terms

  • Animals
  • Citrobacter rodentium / immunology*
  • Citrobacter rodentium / pathogenicity
  • Colon / microbiology
  • Disease Models, Animal
  • Enterobacteriaceae Infections / immunology*
  • Enteropathogenic Escherichia coli / immunology
  • Enteropathogenic Escherichia coli / pathogenicity
  • Escherichia coli Proteins / metabolism
  • Immunity, Innate / immunology*
  • Mice, Inbred C57BL
  • Virulence / immunology

Substances

  • Escherichia coli Proteins

Grants and funding

SH received funding from the European Research Council (erc.europa.eu) under the European Union’s Seventh Framework Programme (FP/ 2007-2013), ERC Grant Agreement n. 281904 (ERC-2013-StG-281904) and from the Swiss National Science Foundation (www.snf.ch; Grants 310030_138452/1 and 31003A_169791/1). SB was supported by a Boehringer Ingelheim Fonds (www.bifonds.de) PhD Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.